v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:        
Net loss   $ (20,722) $ (11,128)  
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation expense   6,450 2,620  
Royalty purchase agreement asset impairment   1,575    
Change in fair value of contingent consideration under RPAs, AAAs, and CPPAs   (75)    
Common stock contribution to 401(k)   123 85  
Amortization of intangible assets $ 224 673    
Depreciation   2 7  
Non-cash lease expense   115 127  
Change in fair value of equity securities   121 330  
Changes in assets and liabilities:        
Trade and other receivables, net   (42) 193  
Prepaid expenses and other assets   (202) (343)  
Accounts payable and accrued liabilities   (554) 596  
Income taxes payable     (91)  
Operating lease liabilities   (120) (144)  
Unearned revenue recognized under units-of-revenue method   (1,575) (1,241)  
Net cash used in operating activities   (14,231) (8,989)  
Cash flows from investing activities:        
Payments of consideration under RPAs, AAAs and CPPAs   (14,650) (8,000)  
Receipts under RPAs, AAAs and CPPAs   8,428 3,026  
Net cash used in investing activities   (6,222) (4,974)  
Cash flows from financing activities:        
Payment of preferred stock dividends   (4,104) (4,104)  
Proceeds from exercise of options and other share-based compensation   208 2,373  
Taxes paid related to net share settlement of equity awards   (5) (1,398)  
Net cash used in financing activities   (3,901) (3,129)  
Net decrease in cash, cash equivalents and restricted cash   (24,354) (17,092)  
Cash, cash equivalents and restricted cash at the beginning of the period   57,826 95,377 $ 95,377
Cash, cash equivalents and restricted cash at the end of the period 33,472 33,472 78,285 $ 57,826
Supplemental Cash Flow Information:        
Cash paid for taxes     95  
Right-of-use assets obtained in exchange for operating lease liabilities   85    
Non-cash investing and financing activities:        
Preferred stock dividend accrual $ 1,368 1,368 $ 1,368  
Estimated fair value of contingent consideration under the LadRx Agreements   1,000    
Accrual of contingent consideration under the Affitech CPPA   $ 3,000    

Source